Search
for
Sort by
Research 811–840 of 1000+
- Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis
- Coregulation of Genetic Programs by the Transcription Factors NFIB and STAT5
- Beneficial effect of spironolactone on androgenic alopecia
- Sleep disturbances in women with polycystic ovary syndrome
- Defining hyperandrogenaemia according to the free androgen index in Chinese women: a cross-sectional study
- Characterization of metabolic changes in the phenotypes of women with polycystic ovary syndrome in a large Mediterranean population from Sicily
- Serum vascular endothelial growth factor B is elevated in women with polycystic ovary syndrome and can be decreased with metformin treatment
- Low-dose (2.5 mg/day) finasteride treatment in hirsutism
- Medium-dose prednisolone pulse therapy in alopecia areata
- miR-761-hepcidin/Gpx4 pathway contribute to unexplained liver dysfunction in polycystic ovary syndrome by regulating liver iron overload and ferroptosis
- Observation of phenotypic variation among Indian women with polycystic ovary syndrome (PCOS) from Delhi and Srinagar
- Age-related differences in the reproductive and metabolic implications of polycystic ovarian syndrome: findings in an obese, United States population
- The pressing need for standardization in epidemiologic studies of PCOS across the globe
- The influence of obesity on Androstenedione to Testosterone ratio in women with polycystic ovary syndrome (PCOS) and hyperandrogenemia
- Comprehensive clinical management of hirsutism
- The investigation and management of severe hyperandrogenism pre- and postmenopause: Non-tumor disease is strongly associated with metabolic syndrome and typically responds to insulin-sensitization with metformin
- Prevalence of polycystic ovary syndrome in Thai University adolescents
- National consensus on the management of patients with hyperandrogenism (2016)
- Studying the correlation of renin-angiotensin-system (RAS) components and insulin resistance in polycystic ovary syndrome (PCOs)
- New onset alopecia and hirsutism in a postmenopausal women
- Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome
- Cutaneous manifestations of diabetic peripheral neuropathy
- Prevalence of hyperprolactinaemia in female premenopausal blood donors
- A retrospective study of thyroid structural abnormalities in alopecia patients
- BIOACTIVE AND PERIPHERAL ANDROGENS IN PREPUBERTAL SIMPLE HYPERTRICHOSIS
- Clinical and histopathological characteristics in patients with scarring folliculitis type of acne inversa
- Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome
- Operative transvaginal hydrolaparoscopy improve ovulation rate after clomiphene failure in polycystic ovary syndrome
- Scalp hair 17‐hydroxyprogesterone and androstenedione as a long‐term therapy monitoring tool in congenital adrenal hyperplasia
- Clinical and laboratory indicators of polycystic ovary syndrome in Chinese Han nationality with different Rotterdam criteria-based phenotypes